Literature DB >> 28666633

Mismatch negativity as a biomarker of theta band oscillatory dysfunction in schizophrenia.

Daniel C Javitt1, Migyung Lee2, Joshua T Kantrowitz2, Antigona Martinez2.   

Abstract

Mismatch negativity (MMN) is among the best established biomarkers of cortical dysfunction in schizophrenia. MMN generators are localized primarily to primary and secondary auditory regions, and are known to reflect activity mediated by cortical N-methyl-d-aspartate-type glutamate receptors (NMDAR). Nevertheless, mechanisms underlying MMN generation at the local circuit level remain incompletely understood. This review synthesizes recent advances in circuit-level conceptualization of MMN based upon neuro-oscillatory findings. In the neuro-oscillatory (aka event-related spectral perturbation, ERSP) approach, responses to sensory stimuli are decomposed into underlying frequency bands prior to analysis. MMN reflects activity primarily in theta (4-7Hz) frequency band, which is thought to depend primarily upon interplay between cortical pyramidal neurons and somatostatin (SST)-type local circuit GABAergic interneurons. Schizophrenia-related deficits in theta generation are also observed not only in MMN, but also in other auditory and visual contexts. At the local circuit level, SST interneurons are known to maintain tonic inhibition over cortical pyramidal interneurons. SST interneurons, in turn, are inhibited by a class of interneurons expressing vasoactive intestinal polypeptide (VIP). In rodents, SST interneurons have been shown to respond differentially to deviant vs. standard stimuli, and inhibition of SST interneurons has been found to selectively inhibit deviance-related activity in rodent visual cortex. Here we propose that deficits in theta frequency generation, as exemplified by MMN, may contribute significantly to cortical dysfunction in schizophrenia, and may be tied to impaired interplay between cortical pyramidal neurons and local circuit SST-type GABAergic interneurons.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Auditory; Cortex; Event-related potentials; Glutamate; Mismatch negativity

Mesh:

Substances:

Year:  2017        PMID: 28666633     DOI: 10.1016/j.schres.2017.06.023

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  29 in total

Review 1.  Auditory System Target Engagement During Plasticity-Based Interventions in Schizophrenia: A Focus on Modulation of N-Methyl-D-Aspartate-Type Glutamate Receptor Function.

Authors:  Joshua T Kantrowitz; Neal R Swerdlow; Walter Dunn; Sophia Vinogradov
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-02-22

2.  Neurophysiologic measures of target engagement predict response to auditory-based cognitive training in treatment refractory schizophrenia.

Authors:  William C Hochberger; Yash B Joshi; Michael L Thomas; Wendy Zhang; Andrew W Bismark; Emily B H Treichler; Melissa Tarasenko; John Nungaray; Joyce Sprock; Lauren Cardoso; Neal Swerdlow; Gregory A Light
Journal:  Neuropsychopharmacology       Date:  2018-10-30       Impact factor: 7.853

3.  Decomposing the constituent oscillatory dynamics underlying mismatch negativity generation in schizophrenia: Distinct relationships to clinical and cognitive functioning.

Authors:  W C Hochberger; Y B Joshi; W Zhang; M L Thomas; D L Braff; N R Swerdlow; G A Light
Journal:  Int J Psychophysiol       Date:  2018-12-23       Impact factor: 2.997

4.  The event-related potential component P3a is diminished by identical deviance repetition, but not by non-identical repetitions.

Authors:  Timm Rosburg; Michael Weigl; Ronja Thiel; Ralph Mager
Journal:  Exp Brain Res       Date:  2018-03-22       Impact factor: 1.972

5.  Electrophysiology as a theoretical and methodological hub for the neural sciences.

Authors:  James F Cavanagh
Journal:  Psychophysiology       Date:  2018-12-16       Impact factor: 4.016

Review 6.  Potential Roles of Redox Dysregulation in the Development of Schizophrenia.

Authors:  Diana O Perkins; Clark D Jeffries; Kim Q Do
Journal:  Biol Psychiatry       Date:  2020-04-02       Impact factor: 13.382

7.  Impaired Fixation-Related Theta Modulation Predicts Reduced Visual Span and Guided Search Deficits in Schizophrenia.

Authors:  Elisa C Dias; Abraham C Van Voorhis; Filipe Braga; Julianne Todd; Javier Lopez-Calderon; Antigona Martinez; Daniel C Javitt
Journal:  Cereb Cortex       Date:  2020-05-14       Impact factor: 5.357

Review 8.  Recent Advances in the Early Intervention in Schizophrenia: Future Direction from Preclinical Findings.

Authors:  Kenji Hashimoto
Journal:  Curr Psychiatry Rep       Date:  2019-07-05       Impact factor: 5.285

9.  CDP-choline and galantamine, a personalized α7 nicotinic acetylcholine receptor targeted treatment for the modulation of speech MMN indexed deviance detection in healthy volunteers: a pilot study.

Authors:  Joelle Choueiry; Crystal M Blais; Dhrasti Shah; Dylan Smith; Derek Fisher; Vadim Illivitsky; Verner Knott
Journal:  Psychopharmacology (Berl)       Date:  2020-08-27       Impact factor: 4.530

10.  Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): I. Psychosis superspectrum.

Authors:  Roman Kotov; Katherine G Jonas; William T Carpenter; Michael N Dretsch; Nicholas R Eaton; Miriam K Forbes; Kelsie T Forbush; Kelsey Hobbs; Ulrich Reininghaus; Tim Slade; Susan C South; Matthew Sunderland; Monika A Waszczuk; Thomas A Widiger; Aidan G C Wright; David H Zald; Robert F Krueger; David Watson
Journal:  World Psychiatry       Date:  2020-06       Impact factor: 49.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.